Moreover, hyperactivation of transcription factors such as NFAT1 and increased T-B cell interactions further amplify T cell responsiveness in MS, indicating that altered activation kinetics are a hallmark of the disease [29,30]. Here, NFATC2 is linked to myeloid sarcoma.